| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.04B | 23.60B | 26.74B | 29.34B | 28.76B | 26.66B |
| Gross Profit | 3.12B | 3.46B | 3.84B | 3.56B | 3.47B | 2.74B |
| EBITDA | 625.00M | 1.09B | 1.49B | 1.34B | 1.33B | 1.23B |
| Net Income | -105.00M | 247.00M | 517.00M | 285.00M | 395.00M | 283.00M |
Balance Sheet | ||||||
| Total Assets | 24.53B | 25.12B | 26.73B | 21.46B | 19.70B | 19.04B |
| Cash, Cash Equivalents and Short-Term Investments | 869.00M | 769.00M | 1.58B | 1.17B | 1.45B | 1.16B |
| Total Debt | 4.69B | 4.77B | 3.80B | 3.21B | 2.83B | 3.10B |
| Total Liabilities | 12.05B | 12.34B | 13.01B | 10.94B | 9.58B | 9.43B |
| Stockholders Equity | 12.29B | 12.58B | 13.51B | 10.33B | 9.95B | 9.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.41B | -102.00M | -490.00M | 633.00M | -497.00M |
| Operating Cash Flow | 0.00 | -268.00M | 1.13B | 149.00M | 1.23B | 380.00M |
| Investing Cash Flow | 0.00 | -1.33B | -1.22B | -766.00M | -593.00M | -783.00M |
| Financing Cash Flow | 0.00 | 747.00M | 460.00M | 261.00M | -382.00M | 851.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥46.39B | 7.97 | 8.46% | 2.64% | -6.35% | 18.49% | |
81 Outperform | ¥253.54B | 8.29 | ― | 3.36% | 1.36% | 139.77% | |
78 Outperform | ¥284.51B | 8.56 | 6.37% | 2.88% | 4.86% | 10.95% | |
76 Outperform | $706.48B | 14.05 | 7.20% | 2.41% | -0.73% | 88.36% | |
70 Outperform | ¥56.34B | 14.59 | ― | 0.99% | -0.83% | -27.20% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | ¥5.57B | 8.75 | ― | 2.46% | -9.28% | -219.81% |